TY  -  
T1  - Evaluating the Evidence behind the Novel Strategy of Early Combination from Vision to Implementation 
SN  -  /  
UR  - http://hdl.handle.net/10138/326814 
T3  -  
A1  - Paldanius, Päivi Maria 
A2  -  
PB  -  
Y1  - 2020 
LA  - eng 
AB  - Type 2 diabetes mellitus (T2DM) is a complex and progressive chronic disease characterised by elevating hyperglycaemia and as-sociated need to gradually intensify therapy in order to achieve and maintain glycaemic control. Treating hyperglycaemia with se-quential therapy is proposed to allow holistic assessment of the efficacy and risk-to-benefit ratio of each added component. How-ever, there is an array of evidence supporting the scientific rationale for using synergistic, earlier, modern drug ... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - 3121 General medicine, internal medicine and other clinical medicine; BETA-CELL FUNCTION; TYPE-2 DIABETES-MELLITUS; METFORMIN-TREATED PATIENTS; INTENSIVE INSULIN THERAPY; BLOOD-GLUCOSE CONTROL; DRUG-NAIVE PATIENTS; INITIAL COMBINATION; CLINICAL INERTIA; GLYCEMIC CONTROL; BASAL INSULIN 
N1  -   
PP  -  
ER  -